Aligned Genetics Inc (238120) — Capital Reinvestment Ratio
Aligned Genetics Inc (238120) has a Capital Reinvestment Ratio of 0.24x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩677.20 Million) in capital expenditures (₩165.20 Million). Check 238120 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aligned Genetics Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks Aligned Genetics Inc's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Aligned Genetics Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Aligned Genetics Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for Aligned Genetics Inc from 2019 to 2024. See Aligned Genetics Inc (238120) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ₩3.07 Billion | ₩340.06 Million | ▼ -64.1% |
| 2023 | 0.31x | ₩2.85 Billion | ₩880.42 Million | ▼ -65.7% |
| 2022 | 0.90x | ₩2.22 Billion | ₩2.00 Billion | ▼ -96.3% |
| 2021 | 24.33x | ₩135.97 Million | ₩3.31 Billion | ▲ +799.8% |
| 2020 | 2.70x | ₩35.67 Million | ₩96.43 Million | ▲ +581.3% |
| 2019 | 0.40x | ₩659.29 Million | ₩261.62 Million | — |